Drug Profile
Anti-TCR-alphabeta monoclonal antibody R73
Alternative Names: Alpha-beta-TCR monoclonal antibody R73; Anti-T-cell-receptor-alphabeta antibody R73; Anti-T-cell-receptor-alphabeta monoclonal antibody R73; Anti-TCR-alphabeta antibody R73; Monoclonal antibody R73; R73Latest Information Update: 03 Jul 2002
Price :
$50
*
At a glance
- Originator Unknown
- Developer Aventis Behring LLC; Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action T-cell receptor antigen alpha-beta antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Transplant rejection